Inhibition of HDAC1 and 3 in the Presence of Systemic Inflammation Reduces Retinal Degeneration in a Model of Dry Age-Related Macular Degeneration
Journal of Ocular Pharmacology and Therapeutics · 2024
DOI: 10.1089/jop.2023.0163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Shahid Husain und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Mice, Inbred C57BL, Histone Deacetylase Inhibitors, Disease Models, Animal, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, USA.
Förderung
- NEI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Husain, S., Obert, E., Singh, S., & Schnabolk, G. (2024). Inhibition of HDAC1 and 3 in the Presence of Systemic Inflammation Reduces Retinal Degeneration in a Model of Dry Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2023.0163
Vancouver
Husain S, Obert E, Singh S, Schnabolk G. Inhibition of HDAC1 and 3 in the Presence of Systemic Inflammation Reduces Retinal Degeneration in a Model of Dry Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2023.0163
BibTeX
@article{Husain2024,
author = {Husain, Shahid and Obert, Elisabeth and Singh, Sudha and Schnabolk, Gloriane},
title = {Inhibition of HDAC1 and 3 in the Presence of Systemic Inflammation Reduces Retinal Degeneration in a Model of Dry Age-Related Macular Degeneration},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2024},
doi = {10.1089/jop.2023.0163}
}
EUVIMED